Placental Oxidative Stress Alters Expression of Murine Osteogenic Genes and Impairs Fetal Skeletal Formation

Placenta

Volumn 29, Issue 9, 2008, Pages 802-808

  Prater, M R ^a,b   Laudermilch, C L ^b   Liang, C ^b   Holladay, S D ^b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Antioxidant; C57BL 6 mouse; Developmental origins of health and disease; Methylnitrosourea; Osteogenesis; Oxidative stress; Placenta; Quercetin

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 1BETA; METHYLNITROSOUREA; QUERCETIN; SCATTER FACTOR; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE STRENGTH; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; FINGER MALFORMATION; FOOD INTAKE; FORELIMB; GENE EXPRESSION; HINDLIMB; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OLIGODACTYLIA; OXIDATIVE STRESS; POLYDACTYLY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNDACTYLY; TROPHOBLAST; WEBBING;

ANIMALS; FEMALE; FORELIMB; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEPATOCYTE GROWTH FACTOR; HINDLIMB; IMMEDIATE-EARLY PROTEINS; INTERFERON TYPE I; INTERLEUKIN-1BETA; MALE; MEMBRANE PROTEINS; METHYLNITROSOUREA; MICE; MICE, INBRED C57BL; OSTEOGENESIS; OXIDATIVE STRESS; PLACENTA DISEASES; PREGNANCY; QUERCETIN; STEM CELL FACTOR;

EID: 50249171811     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.06.010     Document Type: Article

References (45)

1. Harvey N., and Cooper C. The developmental origins of osteoporotic fracture. J Br Menopause Soc 10 (2004) 14-15 29
2. Barker D.J. The fetal and infant origins of disease. Eur J Clin Invest 25 (1995) 457-463
3. Cooper C., Westlake S., Harvey N., Javaid K., Dennison E., and Hanson M. Review: developmental origins of osteoporotic fracture. Osteoporos Int 17 (2006) 337-347
4. Javaid M.K., and Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab 16 (2002) 349-367
5. Hales C.N., and Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35 (1992) 595-601
6. Jansson T., and Powell T.L. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 113 (2007) 1-13
7. DeSesso J.M. Cell death and free radicals: a mechanism for hydroxyurea teratogenesis. Med Hypotheses 5 (1979) 937-951
8. Fantel A.G. Reactive oxygen species in developmental toxicity: review and hypothesis. Teratology 53 (1996) 196-217
9. Gilbert J.S., Ryan M.J., LaMarca B.B., Sedeek M., Murphy S.R., and Granger J.P. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294 (2008) H541-H550
10. Loeken M.R. Free radicals and birth defects. J Matern Fetal Neonatal Med 15 (2004) 6-14
11. Sengupta B., Uematsu T., Jacobsson P., and Swenson J. Exploring the antioxidant property of bioflavonoid quercetin in preventing DNA glycation: a calorimetric and spectroscopic study. Biochem Biophys Res Commun 339 (2006) 355-361
12. Yuan B., Ohyama K., Bessho T., Uchide N., and Toyoda H. Imbalance between ROS production and elimination results in apoptosis induction in primary smooth chorion trophoblast cells prepared from human fetal membrane tissues. Life Sci 82 (2008) 623-630
13. Prater M.R., Laudermilch C.L., and Holladay S.D. Does immune stimulation or antioxidant therapy reduce MNU-induced placental damage via activation of Jak-STAT and NF-κB signaling pathways?. Placenta 28 (2007) 566-570
14. Tricker A.R. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev 6 (1997) 226-268
15. Cindrova-Davies T., Spasic-Boskovic O., Jauniaux E., Charnock-Jones D.S., and Burton G.J. NF-κB, p38, and stress-activated protein kinase MAP kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 170 (2007) 1511-1520
16. Mabrouk G.M., Moselhy S.S., Zohny S.F., Ali E.M., Helal T.E., Amin A.A., et al. Inhibition of methylnitrosourea (MNU) induced oxidative stress and carcinogenesis by orally administered bee honey and Nigella grains in Sprague Dawely rats. J Exp Clin Cancer Res 21 (2002) 341-346
17. Platzek T., Bochert G., Pauli B., Meister R., and Neubert D. Embryotoxicity induced by alkylating agents: 5. Dose-response relationships of teratogenic effects of methylnitrosourea in mice. Arch Toxicol 62 (1988) 411-423
18. Shou S., Scott V., Reed C., Hitzemann R., and Stadler H.S. Transcriptome analysis of the murine forelimb and hindlimb autopod. Dev Dyn 234 (2005) 74-89
19. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., and Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 135 (2005) 2299-2304
20. Kempuraj D., Madhappan B., Christodoulou S., Boucher W., Cao J., Papadopoulou N., et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 145 (2005) 934-944
21. Ruiz P.A., Braune A., Holzlwimmer G., Quintanilla-Fend L., and Haller D. Quercetin inhibits TNF-induced NF-κB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr 137 (2007) 1208-1215
22. Wilms L.C., Hollman P.C., Boots A.W., and Kleinjans J.C. Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. Mutat Res 582 (2005) 155-162
23. Kanter M., Altan M.F., Donmez S., Ocakci A., and Kartal M.E. The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct 25 (2007) 747-752
24. Kim Y.J., Bae Y.C., Suh K.T., and Jung J.S. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 72 (2006) 1268-1278
25. McGartland C.P., Robson P.J., Murray L.J., Cran G.W., Savage M.J., Watkins D.C., et al. Fruit and vegetable consumption and bone mineral density: the Northern Ireland Young Hearts Project. Am J Clin Nutr 80 (2004) 1019-1023
26. Prouillet C., Maziere J.C., Maziere C., Wattel A., Brazier M., and Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67 (2004) 1307-1313
27. Wattel A., Kamel S., Prouillet C., Petit J.P., Lorget F., Offord E., et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP-1. J Cell Biochem 92 (2004) 285-295
28. Nomura T., Hata S., and Kusafuka T. Suppression of developmental anomalies by maternal macrophages in mice. J Exp Med 172 (1990) 1325-1330
29. Gheorghe C., Mohan S., and Longo L.D. Gene expression patterns in the developing murine placenta. J Soc Gynecol Investig 13 (2006) 256-262
30. Martin P. Tissue patterning in the developing mouse limb. Int J Dev Biol 34 (1990) 323-336
31. Lala P.K., and Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 24 (2003) 575-587
32. Dokras A., Gardner L.M., Seftor E.A., and Hendrix M.J. Regulation of human cytotrophoblast morphogenesis by hepatocyte growth factor/scatter factor. Biol Reprod 65 (2001) 1278-1288
33. Hossain M., Irwin R., Baumann M.J., and McCabe L.R. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials 26 (2005) 2595-2602
34. Uehara Y., Minowa O., Mori C., Shiota K., Kuno J., Noda T., et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373 (1995) 702-705
35. Likhachev A.J., Alekandrov V.A., Anisimov V.N., Bespalov V.G., Korsakov M.V., Ovsyannikov A.I., et al. Persistence of methylated purines in the DNA of various rat fetal and maternal tissues and carcinogenesis in the offspring following a single transplacental dose of N-methyl-N-nitrosourea. Int J Cancer 31 (1983) 779-784
36. Glabowski W. The protective effect of stem cell factor (SCF) on in vitro development of preimplantation mouse embryos. Ann Acad Med Stetin 51 (2005) 83-93
37. Lotinun S., Evans G.L., Turner R.T., and Oursler M.J. Deletion of membrane-bound steel factor results in osteopenia in mice. J Bone Miner Res 20 (2005) 644-652
38. Yang J., Cummings E.A., O'Connell C., and Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 108 (2006) 644-650
39. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy?. Semin Immunpathol 29 (2007) 95-113
40. Lee P.Y., Li Y., Richards H.B., Chan F.S., Zhuang H., Narain S., et al. Type I interferon as a novel risk factor for endothelial progenitor cell deletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 56 (2007) 3759-3769
41. Batta K., and Kundu T.K. Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications. Mol Cell Biol 27 (2007) 7603-7614
42. Seidah N.G., Mayer G., Zaid A., Rousselet E., Nassoury N., Poirier S., et al. The activation and physiological functions of the proprotein convertases. Int J Biochem Cell Biol (2008) [Epub ahead of print]
43. Cheah F.C., Jobe A.H., Moss T.J., Newnham J.P., and Kallapur S.G. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamniotitis model. Pediatr Res 63 (2008) 274-279
44. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaite E., and Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26 (1999) 107-116
45. Boots A.W., Li H., Schins R.P., Duffin R., Heemskerk J.W., Bast A., et al. The quercetin paradox. Toxicol Appl Pharmacol 222 (2007) 89-96